Krystal Biotech, Inc. (1KRYS)
MTA
Real-time Data
07:00 AM
Day's Range
289.4052 wk Range
127.15Overview - 1KRYS - Krystal Biotech, Inc.
Key Statistics
Valuation
Enterprise Value
6.68B
P/E (Trailing)
‪42.78‬
PEG Ratio
‪1.09‬
Price / Sales (TTM)
‪19.63‬
Price / Book
‪7.43‬
EV / EBITDA
‪39.18‬
Profitability
Gross Margin
‪94.60%‬
Profit Margin
‪54.81%‬
Operating Margin
‪48.99%‬
Return on Assets
‪9.36%‬
Return on Equity
‪20.12%‬
Ownership
Shares Outstanding
29.59M
Float
23.56M
Held by Insiders
‪10.82%‬
Held by Institutions
‪102.51%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪298.35‬
200-Day Avg
‪244.02‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 1KRYS - Krystal Biotech, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1KRYSMTAKrystal Biotech, Inc.6.14BMarket Cap+56.06%52-week change41.89P/E (Trailing)‪54.81%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+28.94%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+47.15%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1KRYS - Krystal Biotech, Inc.
About
Krystal Biotech, Inc. is a commercial-stage biotechnology company specializing in the discovery, development, and commercialization of genetic medicines for rare diseases. The company is recognized for leveraging advanced gene therapy platforms to address unmet medical needs in dermatology and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
